AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch

February 15, 2022

Biofrontera Inc.: A Compelling Investment in Dermatology

September 9, 2025
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak

August 18, 2025
FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet’s Disease after Reviewing Recent Phase 2 Clinical Study Results

August 18, 2025
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic

August 11, 2025